Survey of Patients With Idiopathic Orbital Inflammation Syndrome
NCT01443000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87
Last updated 2021-11-22
Summary
The purpose of this study is to characterise the clinical features, histopathology and the treatment outcomes of patients with idiopathic orbital inflammation syndrome.
Conditions
- Orbital Ischemic Syndrome
- Orbital Pseudotumor
Sponsors & Collaborators
-
Ministry of Health, France
collaborator OTHER_GOV -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Sébastien ABAD, MD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-03
- Primary Completion
- 2017-06-03
- Completion
- 2017-06-03
Countries
- France
Study Locations
More Related Trials
-
Genetics and Epigenetics of Graves' Orbitopathy
NCT04488406 ·Status: COMPLETED
-
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142 ·Status: RECRUITING
-
Relevance and Efficiency of SecOnd Line Workup for Uveitis
NCT06102408 ·Status: NOT_YET_RECRUITING
-
From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP
NCT04174066 ·Status: UNKNOWN
-
Quality of Life in Patients With Auto-inflammatory Diseases
NCT03569644 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
INS, B Cells and Microbiota
NCT04924712 ·Status: RECRUITING
-
Lyon Sarcoid Uveitis Cohort
NCT03863782 ·Status: RECRUITING
-
Tocilizumab for Patients With Giant Cell Arteritis
NCT01450137 ·Status: COMPLETED ·Phase: PHASE2
-
Juvenile Autoimmune Necrotizing Myopathies
NCT04295785 ·Status: UNKNOWN
-
Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases
NCT02280902 ·Status: COMPLETED
-
Biomarkers in Giant Cells Arteritis
NCT02844023 ·Status: TERMINATED ·Phase: NA
-
Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis
NCT05168475 ·Status: TERMINATED ·Phase: PHASE2
-
Neurosarcoidosis : Initial Presentation and Disease Course
NCT04911348 ·Status: UNKNOWN
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4
-
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
NCT03371095 ·Status: COMPLETED ·Phase: PHASE3
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Collection and Analysis of the Clinical and Biological Characteristics of Patients Treated for Giant Cells ARTEitis (Horton's Disease)
NCT04142515 ·Status: COMPLETED
-
Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.
NCT02993133 ·Status: COMPLETED ·Phase: PHASE3
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
NCT06273748 ·Status: RECRUITING
-
Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
NCT06940661 ·Status: RECRUITING ·Phase: PHASE2
-
CHronic Nonbacterial Osteomyelitis International Registry
NCT04725422 ·Status: RECRUITING
-
Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
NCT01446380 ·Status: UNKNOWN
-
A Prospective & Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases
NCT04509570 ·Status: COMPLETED ·Phase: NA